Spyre Therapeutics prices $350 million public offering of common stock
SYRE•Spyre Therapeutics priced a $350 million public offering of 4,117,648 shares at $85 per share.
1. Offering pricing
Spyre Therapeutics priced a public offering of 4,117,648 shares at $85 per share, for total proceeds of $350 million.
